Connect with us
[ad_1] Nathan Frei, a former active-duty infantry officer, who served from 2011 to 2015 and Judge Advocate General in the U.S. Army, first noticed issues with...
[ad_1] Here’s an update on the health care and financial holdings in Jim Cramer’s Charitable Trust, the portfolio we use at the CNBC Investing Club. Jim ran...
[ad_1] Traders work on the floor of the New York Stock Exchange on Wall Street in New York City. Angela Weiss | Afp | Getty Images...
[ad_1] Vials and a medical syringe seen displayed in front of the Food and Drug Administration (FDA) of the United States logo. FDA finds the COVID-19...
[ad_1] A federal appeals court rejected Johnson & Johnson ‘s plan to use a legal strategy to push about 38,000 talc lawsuits into bankruptcy court, hampering...
[ad_1] Nearly two years after biotechnology stocks began to tumble, executives at small and midsize companies in the space are finally accepting that share prices aren’t...
[ad_1] We’re growing increasingly worried about some richly valued companies in our portfolio, including the likes of Nvidia (NVDA) and Microsoft (MSFT). Expensive stocks remain out...
[ad_1] We step into the new year with a largely unchanged macroeconomic backdrop and a recession waiting for us. However, investors can maintain a healthy portfolio if they...
[ad_1] Stock futures traded lower Monday as investors remained keyed on interest rate policy from the Federal Reserve and as a surge in China stocks over...
[ad_1] Johnson & Johnson is spending more than $16 billion to move deeper into treating heart disease and continue a shift started last year away from...
[ad_1] Johnson & Johnson topped third-quarter expectations thanks to growth in pharmaceutical sales, but the health care giant continued to tread cautiously with its outlook due...
[ad_1] This story is part of CNN Business’ Nightcap newsletter. To get it in your inbox, sign up for free, here. New York CNN Business — ...